Literature DB >> 20024552

An aggressive and lethal course of Churg-Strauss syndrome with alveolar hemorrhage, intestinal perforation, cardiac failure and peripheral neuropathy.

Aydin Çiledağ1, Hülya Deniz, Serpil Eledağ, Canan Özkal, Nurşen Düzgün, Selim Erekul, Demet Karnak.   

Abstract

Churg-Strauss syndrome (CSS) is a rare type of necrotizing vasculitis affecting small to medium-sized vessels typically characterized by asthma, lung infiltrates, necrotizing granulomas and hypereosinophilia. Herein, we describe a case of CSS presenting severe and aggressive course. A 35-year-old male patient with weight loss, dyspepsia, dyspnea and hemoptysis was admitted. The laboratory analyses indicated a remarkable eosinophilia, elevated levels of serum total IgE and positive cANCA. Thorax CT findings were suggestive of alveolar hemorrhage. Bronchoalveolar lavage revealed alveolar hemorrhage with eosinophilia and transbronchial lung biopsy showed eosinophilic vasculitis. Cardiac enzymes were increased and murmurs were audible revealing cardiomyopathy proven by echocardiography. Pulse cyclophosphamide and methyl prednisolone was immediately started. On the 21st day, intestinal perforation developed and urgent surgery was performed. During a follow-up, although a radiological improvement was observed in the chest X-ray, cardiac failure, peripheral neuropathy and skin lesions developed and high-dose intravenous immunoglobulin and anti-TNF therapy (adalimumab) were applied. Despite the therapy, he died from heart failure and septicemia at 68th day of therapy.

Entities:  

Mesh:

Year:  2009        PMID: 20024552     DOI: 10.1007/s00296-009-1321-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  18 in total

1.  Churg Strauss syndrome presenting as acute neuropathy resembling Guillain Barré syndrome: case report.

Authors:  Nilo Riva; Federica Cerri; Calogera Butera; Stefano Amadio; Angelo Quattrini; Raffaella Fazio; Mauro Comola; Giancarlo Comi
Journal:  J Neurol       Date:  2008-12-08       Impact factor: 4.849

2.  Churg-Strauss syndrome: report of a case without preexisting asthma.

Authors:  K R Chen; Y Ohata; M Sakurai; H Nakayama
Journal:  J Dermatol       Date:  1992-01       Impact factor: 4.005

3.  Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.

Authors:  W H Schmitt; E Csernok; S Kobayashi; A Klinkenborg; E Reinhold-Keller; W L Gross
Journal:  Arthritis Rheum       Date:  1998-03

4.  Churg-Strauss syndrome and sudden cardiac death.

Authors:  J Fernando Val-Bernal; Marta Mayorga; Eva García-Alberdi; J Andrés Pozueta
Journal:  Cardiovasc Pathol       Date:  2003 Mar-Apr       Impact factor: 2.185

5.  Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients.

Authors:  R Solans; J A Bosch; C Pérez-Bocanegra; A Selva; P Huguet; J Alijotas; R Orriols; L Armadans; M Vilardell
Journal:  Rheumatology (Oxford)       Date:  2001-07       Impact factor: 7.580

6.  Churg-Strauss syndrome (allergic granulomatous angitis) presenting with ileus caused by ischemic ileal ulcer.

Authors:  T Kaneki; A Kawashima; T Hayano; T Honda; K Kubo; T Koizumi; M Sekiguchi; H Ichikawa; K Matsuzawa; T Katsuyama
Journal:  J Gastroenterol       Date:  1998-02       Impact factor: 7.527

7.  Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.

Authors:  L Guillevin; P Cohen; M Gayraud; F Lhote; B Jarrousse; P Casassus
Journal:  Medicine (Baltimore)       Date:  1999-01       Impact factor: 1.889

8.  [Churg-Strauss syndrome: outcome and long-term follow-up of 38 patients from a single Italian centre].

Authors:  C Baldini; A Della Rossa; S Grossi; E Catarsi; R Talarico; A d'Ascanio; M Mosca; R Neri; A Tavoni; S Bombardieri
Journal:  Reumatismo       Date:  2009 Apr-Jun

9.  Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin.

Authors:  Naomi Tsurikisawa; Masami Taniguchi; Hiroshi Saito; Hideo Himeno; Akihiko Ishibashi; Shunsuke Suzuki; Kazuo Akiyama
Journal:  Ann Allergy Asthma Immunol       Date:  2004-01       Impact factor: 6.347

Review 10.  Update in the diagnosis and management of pulmonary vasculitis.

Authors:  Stephen K Frankel; Gregory P Cosgrove; Aryeh Fischer; Richard T Meehan; Kevin K Brown
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

View more
  4 in total

Review 1.  TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.

Authors:  Francisco Silva; Marcela Cisternas; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

2.  Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment.

Authors:  Gunter Assmann; Marc Molinger; Michael Pfreundschuh; Rainer Bohle; Vincent Zimmer
Journal:  Springerplus       Date:  2014-08-04

3.  Multiple perforations and fistula formation following corticosteroid administration: A case report.

Authors:  Jing-Ni He; Zhong Tian; Xu Yao; Hang-Yu Li; Yun Yu; Yuan Liu; Jin-Gang Liu
Journal:  World J Clin Cases       Date:  2017-02-16       Impact factor: 1.337

Review 4.  Vasculitis: From Target Molecules to Novel Therapeutic Approaches.

Authors:  Sang-Wan Chung
Journal:  Biomedicines       Date:  2021-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.